Reviva Pharmaceuticals Holdings Inc (RVPH)
1.66
-0.05
(-2.92%)
USD |
NASDAQ |
May 17, 16:00
1.66
0.00 (0.00%)
After-Hours: 20:00
Reviva Pharmaceuticals Holdings Cash from Operations (Quarterly): -11.73M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -11.73M |
| December 31, 2023 | -8.876M |
| September 30, 2023 | -6.179M |
| June 30, 2023 | -5.317M |
| March 31, 2023 | -7.951M |
| December 31, 2022 | -4.691M |
| September 30, 2022 | -4.002M |
| June 30, 2022 | -4.001M |
| March 31, 2022 | -6.267M |
| Date | Value |
|---|---|
| December 31, 2021 | -3.902M |
| September 30, 2021 | -2.309M |
| June 30, 2021 | -1.341M |
| March 31, 2021 | -3.116M |
| December 31, 2020 | -2.936M |
| September 30, 2020 | -0.7156M |
| June 30, 2020 | -0.3547M |
| March 31, 2020 | -0.0607M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-11.73M
Minimum
Mar 2024
-0.0607M
Maximum
Mar 2020
-4.338M
Average
-4.001M
Median
Jun 2022
Cash from Operations (Quarterly) Benchmarks
| AbbVie Inc | 4.04B |
| ABVC BioPharma Inc | -0.4795M |
| Sutro Biopharma Inc | -64.74M |
| Flora Growth Corp | -1.131M |
| Journey Medical Corp | -5.019M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 0.332M |
| Free Cash Flow | -32.10M |
| Free Cash Flow Per Share (Quarterly) | -0.3923 |
| Free Cash Flow Yield | -74.48% |